(Q40551498)

21 September 2017

1 reference

title

Multiple actions of somatostatin in neoplastic disease (English)

1 reference

21 September 2017

Reubi JC

1

1 reference

PubMed ID

7792931

21 September 2017

Laissue JA

series ordinal

2

1 reference

21 September 2017

1 March 1995

1 reference

Trends in Pharmacological Sciences

21 September 2017

1 reference

21 September 2017

16

1 reference

21 September 2017

110-115

1 reference

21 September 2017

3

1 reference

The role of peptides and their receptors as tumor markers.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Molecular biology of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Inhibitory effect of somatostatin-14 and some analogues on human natural killer cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Suppression of superoxide release from human monocytes by somatostatin-related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Effects of a somatostatin analogue (SMS 201-995) on the growth and development of hepatic tumour derived by intraportal injection of Walker cells in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Mucosal abnormalities at the anastomosis site in patients who have had intestinal resection for colonic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Alterations in receptors for sensory neuropeptides in human inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Unexpected growth-stimulatory effect of somatostatin analogue on cultured human pancreatic carcinoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SRIH receptor content.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2988992-0

7 January 2021

10.1016/S0165-6147(00)88992-0

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7792931